1. Short title This Act may be cited as the Safeguarding American Genetic Data Act of 2023 . 2. Prohibition on contracting with certain biotechnology providers (a) Designation of Federal entity Not later than 30 days after the date of the enactment of this Act, the President shall designate a Federal entity (in this section referred to as the Federal entity ) to establish guidance to ensure that Executive agencies do not directly procure or obtain any covered biotechnology equipment or service. The Federal entity, the head of which shall be the Director of the Office of Management and Budget, shall include the Secretary of Defense, the Attorney General, the Secretary of Health and Human Services, the Secretary of Commerce, the Director of National Intelligence, the Secretary of Homeland Security, the Secretary of State, and the heads of other appropriate Federal agencies as identified by the President. (b) Policy, guidance, and regulations (1) Recommendations Not later than one year after the date of the enactment of this Act, the Federal entity, in coordination with the Federal Acquisition Regulatory Council and other heads of Executive agencies as determined appropriate by the President, shall issue guidance and recommend the establishment of policy and regulations, as necessary, to implement the requirements of this section. (2) OMB policy Not later than 180 days after the date of issuance of recommendations under paragraph (1), the Director of the Office of Management and Budget shall issue any policy necessary to effectuate the recommendations. (3) Federal acquisition regulation Not later than one year after the date of issuance of recommendations under paragraph (1), the Federal Acquisition Regulatory Council shall revise the Federal Acquisition Regulation as necessary to implement the requirements of this section. (4) Effective date Any prohibition included in the guidance established by the Federal entity in accordance with paragraph (1) shall take effect not later than one year after the establishment